The 15 references in paper L. Sklyar Ph., E. Markelova V., Л. Скляр Ф., Е. Маркелова В. (2014) “К ВОПРОСУ ОБ ИММУНОЛОГИЧЕСКИХ КРИТЕРИЯХ ЭФФЕКТИВНОСТИ ПРОТИВОВИРУСНОЙ ТЕРАПИИ ХРОНИЧЕСКОГО ВИРУСНОГО ГЕПАТИТА С // TO THE QUESTION ABOUT IMMUNOLOGIES CRITERIAS OF EFFICIENCY OF ANTIVIRUS THERAPY OF A CHRONIC VIRUS HEPATITES C” / spz:neicon:mimmun:y:2006:i:6:p:673-678

1
Никулкина Е.Н., Крель П.Е., Лопаткина Т.Н., Игнатова Т.М. Эффективность комбинированной терапии пегинтерфероном альфа-2b (ПегИнтроном) и рибавирином (Ребетолом) первичных больных хроническим гепатитом С // Клинич. фармакология и терапия. – 2004. – Т. 13. - No 2. – С. 4852.
(check this in PDF content)
2
Amaraa R., Mareckova H., Urbanek P. Immunological predictors of different responses to combination therapy with interferon alpha and ribavirin in patients with chronic hepatitis // J. Gastroenterology. 2003. – Vol. 38. - N 3. – P. 254.
(check this in PDF content)
3
Berg T., Sarrazin C., Herrmann E. Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy // Hepatology. – 2003. – Vol. 37. – P. 600-609.
(check this in PDF content)
4
Burroughs A.K. Posttransplantation prevention and treatment of recurrent hepatitis C // Liver transpl. – 2000. – Vol. 6 - N 2. – P. 35-40.
(check this in PDF content)
5
Craxi A., Licata A. Clinical trial results of peginterferons in combination with ribavirin // Semin. Liver Dis. – 2003. – Vol. 23. - N 1. – P. 35-46.
(check this in PDF content)
6
Hadziyannis S.J., Sette ir H., Morgan T.R. Peginterferon alfa-2a and ribavirine combination therapy in chronic hepatitis C. A randomized study of treatment duration and ribavirine dose // Ann. Intern. Med. – 2004. – Vol. 140. – P. 346-355.
(check this in PDF content)
7
Gopal D.V., Rabcin J.M., Berk B.S. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin // Liver transpl. – 2001. – N 7. – P. 181-190.
(check this in PDF content)
8
McHutchison J., Gordon S.C., Schiff E.R. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C // N. Engl. J. Med. – 1998. – Vol. 339. – P. 14851492.
(check this in PDF content)
9
Meurs E. Mechanisms of antiviral action of interferon // Virologie. – 1997. – Vol. 1. – P. 481-498.
(check this in PDF content)
10
National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C: 2002 // Hepatology. – 2002. – Vol. 36. – P. 2-20.
(check this in PDF content)
11
Peters M. Action of cytokines on the immune response and viral interactions: an overview // Hepatology. – 1996. – Vol. 23. – P. 909-916.
(check this in PDF content)
12
Pestka S., Krause C.D., Walter M.R. Interferons, interferon-like cytokines, and their receptors // Immunological reviews. – 2004. – Vol. 202. – P. 28-32.
(check this in PDF content)
13
Poynard T., McHutchison J., Manns M. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C // Gastroenterology. – 2002. – Vol. 122. – P. 1303-1313.
(check this in PDF content)
14
Randall G., Rice C.M. Hepatitis C virus cell culture replication systems: their potential use for the development of antiviral therapies // Curr. Opin. Infect. Dis. – 2001. - Vol. 14. – P.743-747.
(check this in PDF content)
15
Wedemeyer H., Cornberg B., Manns M.P. Immunopathogenesis and therapy of hepatitis C // Liver Immunology / M. ed Gershwin, London: Academic Press. - 2003. – Ch. 16. – P. 223-248. поступила в редакцию 21.03.2006
(check this in PDF content)